Good Manufacturing Practices (GMP) for Schedule D Drugs, Part 2, Human Blood and Blood Components

Contact Name : Drugs GMP Inspection Unit
Tel : (613) 957-1492
Fax : (613) 952-9805
E-Mail : GMP_Questions_BPF@hc-sc.gc.ca

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

Cover Page

Our Mandate :

To promote good nutrition and informed use of drugs, food, medical devices and natural health products, and to maximize the safety and efficacy of drugs, food, natural health products, medical devices, biologics and related biotechnology products in the Canadian marketplace and health system.

Health Products and Food Branch Inspectorate

Annex to the GMP Guidelines

Good Manufacturing Practices for Schedule D Drugs
Part 2
Human Blood and Blood Components

Supersedes :
First draft, March 24, 1998

Date issued :
December 1, 1999

Date of implementation :
December 1, 1999

*Revisions were made to this document on 2002-02-25 to reflect changes to the Health Products and Food Branch organizational structure. There were no other changes made to the content of the document.

Ce document est aussi disponible en français.